Microbiology and epidemiology of enteroaggregative Escherichia coli isolated from UK residents in England, 2016–2023: what are the risks to public health?
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Ching-Ying J Poh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Bacteria Reference Unit, UK Health Security Agency, London NW9 5HT, UK. Hauptthemen laut MEDLINE: Escherichia coli Infections, Escherichia coli. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research Health Protection Research Unit.
Abstract (Originalsprache)
Introduction
Following two large foodborne outbreaks of the gastrointestinal pathogen, enteroaggregative Escherichia coli (EAEC), in Germany in 2011 and the UK in 2014, the UK Health Security Agency (UKHSA) implemented enhanced surveillance strategies for EAEC. Gap Statement. The surveillance of diarrhoeagenic E. coli in England focuses on Shiga toxin-producing E. coli (STEC), and the true clinical and community burden of EAEC is unknown. This gap extends globally, as many countries lack the infrastructure, diagnostic tools and healthcare facilities to resource surveillance programmes for EAEC.
Aim
The aim of the study was to review the microbiological typing data and demographic data linked to isolates and cases diagnosed from 2016 to 2023 and to assess the risk to public health. Methodology. Faecal samples that tested positive by PCR for diarrhoeagenic E. coli at local microbiology diagnostic laboratories were referred to the UKHSA for confirmation and culture. Isolates identified as EAEC were sequenced on the Illumina HiSeq and NextSeq platforms. Sequence type, serotype and antimicrobial resistance (AMR) profile were derived from the genome sequence. Age, sex and travel histories were linked to the typing data.
Results
There was a total of 1,402 notifications of EAEC, exhibiting a fivefold increase in diagnoses from 93 in 2016 to 524 in 2023. The most common sequence types (STs) were ST34 ( n =202/1,402, 14.4%), ST10 ( n =185/1,402, 13.2%), ST200 ( n =183/1,402, 13.1%) and ST678 ( n =101/1,402, 7.2%), and the most common serotypes were O92:H33 ( n =130/1,402, 9.3%), O175:H31 ( n =78/1,402, 5.6%) and O99:H10 ( n =78/1,402, 5.6%). Most cases were female ( n =748/1,372, 54.5%) and/or were aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastrointestinal Bacteria Reference Unit, UK Health Security Agency, London NW9 5HT, UK.
- National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections, University of East Anglia, Norwich NR4 7TJ, UK.
- Gastrointestinal Infections & Food Safety (One Health), UK Health Security Agency, London, UK.
Förderung
- National Institute for Health Research Health Protection Research Unit
Zitieren
APA
Poh, C. J., Rodwell, E. V., Greig, D. R., Nair, S., Chattaway, M. A., & Jenkins, C. (2025). Microbiology and epidemiology of enteroaggregative Escherichia coli isolated from UK residents in England, 2016–2023: what are the risks to public health?. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002097
Vancouver
Poh CJ, Rodwell EV, Greig DR, Nair S, Chattaway MA, Jenkins C. Microbiology and epidemiology of enteroaggregative Escherichia coli isolated from UK residents in England, 2016–2023: what are the risks to public health?. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002097
BibTeX
@article{Poh2025,
author = {Poh, Ching-Ying J and Rodwell, Ella V and Greig, David R and Nair, Satheesh and Chattaway, Marie A and Jenkins, Claire},
title = {Microbiology and epidemiology of enteroaggregative Escherichia coli isolated from UK residents in England, 2016–2023: what are the risks to public health?},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002097}
}
EUVIMED